By Pat Anson, Editor
A bipartisan group of congressmen is demanding the Food and Drug Administration “act without delay” by restricting access to Vicodin and other hydrocodone products, the most widely used and abused narcotic painkiller in the U.S.
Last month an advisory panel to the FDA voted 19 to 10 to reclassify hydrocodone products from a Schedule III controlled substance to a Schedule II drug, which will make it harder for pain patients to obtain or get refills for. The FDA, which usually follows the recommendations of its advisory panels, has not yet made a final decision on the matter.
Read more at National Pain Report.
(0) Readers Comments
November 12, 2012
October 08, 2012
September 12, 2012
July 23, 2012
June 11, 2019
April 05, 2019
April 01, 2019
March 18, 2019
Oh boy...Your right we hate to hear this. You know why people in pain
Doesn't the 1.5 billion is spent a year give credence to its possitive
Many MS drugs cause PML and deaths too these drugs all need t
I knew him when he was breaking in at a couple of Los Angeles TV stati
Saying there is a 'twist' is the worst type of spoile